RFK Jr. Defends Trump's Math on Drug Pricing Claims
Robert F. Kennedy Jr. has come under scrutiny for defending controversial statements made by former President Donald Trump regarding pharmaceutical pricing calculations. The debate centers on Trump's assertion that his administration achieved significant drug cost savings, claims that critics argue are based on unconventional mathematical interpretations.
According to the controversy, Trump's team calculated savings by comparing drug prices to what they claimed were inflated baseline figures, rather than using standard industry metrics. Kennedy's defense of these calculations has drawn criticism from healthcare analysts and economists who argue the methodology lacks transparency and scientific rigor.
The core issue involves how savings are measured in pharmaceutical negotiations.
